The short answer
Evaluation may include lymph-node or tissue biopsy, grading, immunophenotyping, imaging, blood tests, and selected marrow assessment. Each result should answer a specific diagnostic, risk, or treatment question.
Evaluation may include lymph-node or tissue biopsy, grading, immunophenotyping, imaging, blood tests, and selected marrow assessment.
Planning may depend on grade, symptoms, tumor burden, stage, pace, transformation concern, health, and goals.
A result can be diagnostic, prognostic, predictive, or useful for monitoring—and these are not identical roles.
Ask which results are confirmed and which remain pending.
Choose how you want to understand this
The full explanation.
What the biopsy shows
A lymph-node biopsy is the starting point. Doctors prefer to remove a whole node, called an excisional biopsy, rather than a small core sample. A whole node shows the pattern a pathologist needs. A hematopathologist studies the tissue under a microscope. This is a doctor who specializes in blood and lymph system disease.
Follicular lymphoma gets a grade from 1 to 3. Grades 1, 2, and 3A behave in a similar, slow-growing way. Grade 3B looks different under the microscope. Doctors usually treat it like a fast-growing lymphoma called diffuse large B-cell lymphoma. The grade on your report can change the treatment plan. Ask which grade you have.
The BCL2 gene change
More than 9 in 10 people with follicular lymphoma have a change in the BCL2 gene. This change comes from a swap between two chromosomes, called a translocation. It lets lymphoma cells survive longer than they should. Finding this change supports the diagnosis. It does not, by itself, decide your treatment. Your pathology report may also list other markers, such as CD20, CD10, and BCL6. These help confirm the exact cell type.
The FLIPI score
Once follicular lymphoma is confirmed, your team may calculate a risk score called the FLIPI. It uses five factors: your age, a blood test called LDH, how many lymph node areas are involved, your hemoglobin level, and the cancer's stage. Each factor adds a point. People with zero or one risk factor tend to do better over ten years than people with four or five risk factors. FLIPI does not predict any single person's outcome. It helps your team plan and compare options.
How these results connect to treatment
Many people with early, slow-growing follicular lymphoma start with watchful waiting. That means no treatment yet, just regular check-ins. This is standard care, not neglect, when the disease is slow and is not causing symptoms.
When treatment does start, it often includes rituximab. This drug targets a protein called CD20 on lymphoma cells. Doctors may combine rituximab with chemotherapy, such as bendamustine or the R-CHOP combination. After a good response, some people get rituximab or a related drug called obinutuzumab as maintenance therapy. That means lower-dose treatment continues for a period to help keep the disease controlled.
For early-stage disease limited to one or two areas, radiation alone can work well. For lymphoma that returns after two or more treatments, newer options include CD19-directed CAR T-cell therapy, which uses lab-engineered immune cells, and mosunetuzumab, a drug that links your own T cells to the lymphoma cells so your immune system can attack them.
What's still pending
Ask your team which results are final and which are still being processed. Chromosome studies, FISH testing, and some biomarker panels take longer than the first microscope report, and your lab can tell you how long. If a decision does not need to be made immediately, it is reasonable to wait for the complete picture rather than plan around a partial report.
What to ask your team
- What grade is my follicular lymphoma, and is it grade 3B managed as an aggressive lymphoma?
- What is my FLIPI score, and what does it mean for planning?
- Does watchful waiting fit my case, or is treatment recommended now?
- If treatment starts, why was this specific combination chosen?
- Were BCL2, CD20, CD10, and BCL6 all checked, and what did each show?
Sources
Words to know
Tap any term to see what it means.
Common questions
Why does the biopsy need to be a whole node?
Doctors prefer to remove a whole node, called an excisional biopsy, rather than take a small core sample, because a whole node shows the pattern a pathologist needs. The tissue is then studied by a hematopathologist, a doctor who specializes in blood and lymph system disease.
What does the grade mean?
Follicular lymphoma gets a grade from 1 to 3. Grades 1, 2 and 3A behave in a similar, slow-growing way. Grade 3B looks different under the microscope, and doctors usually treat it like a fast-growing lymphoma called diffuse large B-cell lymphoma. The grade on your report can change the treatment plan, so ask which grade you have.
What is the BCL2 change?
More than 9 in 10 people with follicular lymphoma have a change in the BCL2 gene. It comes from a swap between two chromosomes, called a translocation, and it lets lymphoma cells survive longer than they should. Finding the change supports the diagnosis, but it does not by itself decide your treatment.
What is the FLIPI score?
A risk score built from five factors: your age, a blood test called LDH, how many lymph node areas are involved, your hemoglobin level, and the cancer's stage. Each factor adds a point, and people with zero or one risk factor tend to do better over ten years than people with four or five. FLIPI does not predict any single person's outcome; it helps your team plan and compare options.
Is watchful waiting normal here?
Yes. Many people with early, slow-growing follicular lymphoma start with watchful waiting, which means no treatment yet, just regular check-ins. This is standard care, not neglect, when the disease is slow and is not causing symptoms.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this guide into a short list for your care team.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-22 what this meansLast updated: 2026-08-17Next planned review: 2027-07-22
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share